| |
 |
|
Class Information
Number: 514/166
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Ortho-hydroxybenzoic acid (i.e., salicyclic acid) or derivative doai > Nitrogen containing (e.g., anilides, etc.)
Description: Subject matter wherein the salicylic acid compound contains nitrogen, e.g., anilides, etc.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7417037 |
Compositions and methods of treatment for inflammatory diseases |
Aug. 26, 2008 |
| 7323452 |
Method for the accelerated in vivo removal of ethanol |
Jan. 29, 2008 |
| 7208483 |
Polymeric delivery agents and delivery agent compounds |
Apr. 24, 2007 |
| 7094431 |
Method of healing skin wounds in mammals and a composition therefor |
Aug. 22, 2006 |
| 7056903 |
Carboxylic acid derivatives as IP antagonists |
Jun. 6, 2006 |
| 7049308 |
C-nitroso compounds and use thereof |
May. 23, 2006 |
| 6855341 |
Anti-viral compositions and methods of making and using the anti-viral compositions |
Feb. 15, 2005 |
| 6833362 |
Method and composition for the accelerated in vivo removal of ethanol |
Dec. 21, 2004 |
| 6730329 |
Zinc containing compositions for anti-viral use |
May. 4, 2004 |
| 6706290 |
Methods for eradication of nanobacteria |
Mar. 16, 2004 |
| 6624153 |
Halogenated antituberculosis agents |
Sep. 23, 2003 |
| 6620785 |
Treatment of Mycobacterial diseases by administration of bactericidal/permeability-increasing protein products |
Sep. 16, 2003 |
| 6593339 |
Use of compounds as antibacterial agents |
Jul. 15, 2003 |
| 6589944 |
Breakers of advanced glycation endproducts |
Jul. 8, 2003 |
| 6551620 |
Pellet formulation for the treatment of the intestinal tract |
Apr. 22, 2003 |
| 6482846 |
Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs |
Nov. 19, 2002 |
| 6475526 |
Zinc containing compositions for anti-viral use |
Nov. 5, 2002 |
| 6455515 |
Salicylohydrazide derivatives, processes and intermediates for their preparation, compositions comprising them, and their use |
Sep. 24, 2002 |
| 6426338 |
Therapy for constipation |
Jul. 30, 2002 |
| 6326364 |
Use of 5-aminosalicylates as antimicrobial agents |
Dec. 4, 2001 |
| 6287601 |
Topical nitric oxide donor compositions |
Sep. 11, 2001 |
| 6277412 |
Pellet-type formulation intended for treating the intestinal tract |
Aug. 21, 2001 |
| 6255298 |
Macrophage scavenger receptor antagonists for use in the treatment of cardiovascular diseases |
Jul. 3, 2001 |
| 6225296 |
Inhibitory effects of synthetic and natural colorant on carcinogenesis VIII |
May. 1, 2001 |
| 6177414 |
Starburst conjugates |
Jan. 23, 2001 |
| 6143735 |
Agent for treating heart diseases |
Nov. 7, 2000 |
| 6143734 |
Nitroso esters of .beta.-oxo-amides and aryl propionic acid derivatives of non-steroidal antiinflammatory drugs |
Nov. 7, 2000 |
| 6117859 |
Method of relieving chronic inflammation by using 5-alkylsulfonylsalicylanilides |
Sep. 12, 2000 |
| 6045827 |
Treatment of equine laminitis |
Apr. 4, 2000 |
| 6043232 |
Nitroso esters of beta-oxo-amides and aryl propionic acid derivatives of non-steroidal antiinflammatory drugs |
Mar. 28, 2000 |
| 6043233 |
Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs |
Mar. 28, 2000 |
| 5958911 |
Method of relieving inflammation by using 5-alkylsulfonylsalicylanilides |
Sep. 28, 1999 |
| 5905073 |
Use of 2-hydroxy-5-phenylazobenzoic acid derivatives as colon cancer chemopreventative and chemotherapeutic agents |
May. 18, 1999 |
| 5889026 |
4-hydroxy-piperodine derivatives |
Mar. 30, 1999 |
| 5869471 |
Methods for the treatment of arthritis using phosphonates and NSAIDS |
Feb. 9, 1999 |
| 5869067 |
Bi-aromatic compounds and pharmaceutical and cosmetic compositions |
Feb. 9, 1999 |
| 5753239 |
Bi-aromatic compounds and pharmaceutical and cosmetic compositions |
May. 19, 1998 |
| 5750559 |
Potentiation of the antireactive-antiasthmatic effect of inhaled loop diuretics by inhaled non-steroidal anti-inflammatory drugs |
May. 12, 1998 |
| 5731302 |
Stable aqueous suspensions of mesalazine |
Mar. 24, 1998 |
| 5725872 |
Composition for foams, notably rectal foams, and foams thus obtained |
Mar. 10, 1998 |
| 5716648 |
Compositions for use in the regulation of subnormal pH values in the intestinal tract and for treatment of bowel diseases |
Feb. 10, 1998 |
| 5668123 |
Method of maintaining remission from venous ulcers with sulphasalazine and its metabolite |
Sep. 16, 1997 |
| 5583113 |
Use of a direct-acting thrombin inhibitor for the manufacture of a medicinal product having thrombolytic activity |
Dec. 10, 1996 |
| 5541170 |
Orally administrable pharmaceutical compositions |
Jul. 30, 1996 |
| 5541171 |
Orally administrable pharmaceutical composition |
Jul. 30, 1996 |
| 5527523 |
Hydroquinone amino-acid esters, methods of preparation, and pharmaceutical or cosmetic compositions containing them |
Jun. 18, 1996 |
| 5519014 |
Treatment of non-inflammatory and non-infectious bowel disorders |
May. 21, 1996 |
| 5498608 |
Use of 2-hydroxy-5-phenylazobenzoic acid derivatives as colon cancer chemopreventative and chemotherapeutic agents |
Mar. 12, 1996 |
| 5405842 |
Treatment of steroid dependent asthmatics |
Apr. 11, 1995 |
| 5366967 |
Potentiation of the anti-reactive-antiasthmatic effect of inhaled loop diuretics by inhaled non-steroidal anti-inflammatory drugs |
Nov. 22, 1994 |
|
|
|
